These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 36066744)

  • 1. Development of the Patient- and Observer-Reported PRUCISION Instruments to Assess Pruritus and Sleep Disturbance in Pediatric Patients with Cholestatic Liver Diseases.
    Gwaltney C; Bean S; Venerus M; Karlsson L; Warholic N; Kjems L; Horn P
    Adv Ther; 2022 Nov; 39(11):5126-5143. PubMed ID: 36066744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the PRUCISION Instruments in Pediatric Patients with Progressive Familial Intrahepatic Cholestasis.
    Gwaltney C; Ivanescu C; Karlsson L; Warholic N; Kjems L; Horn P
    Adv Ther; 2022 Nov; 39(11):5105-5125. PubMed ID: 36066745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative exploration of the visual function impairments and impacts on vision-dependent activities of daily living in Retinitis Pigmentosa and Leber Congenital Amaurosis: content validation of the ViSIO-PRO and ViSIO-ObsRO measures.
    Kay C; Audo I; Naujoks C; Spera C; Fischer MD; Green J; Durham T; Williamson N; Bradley H; Barclay M; Sims J; Banhazi J; Patalano F
    J Patient Rep Outcomes; 2023 Jul; 7(1):74. PubMed ID: 37466759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Novel Tool to Assess the Impact of Itching in Pediatric Cholestasis.
    Kamath BM; Abetz-Webb L; Kennedy C; Hepburn B; Gauthier M; Johnson N; Medendorp S; Dorenbaum A; Todorova L; Shneider BL
    Patient; 2018 Feb; 11(1):69-82. PubMed ID: 28710680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring dengue illness intensity: Development and content validity of the dengue virus daily diary (DENV-DD).
    Jones AM; Saretsky TL; Panter C; Wells JR; White F; Smith V; Kendal H; Russell K; Ruggieri M; Calhoun SR; Gater A; O'Hagan J; Anderson KB; Paz-Soldan VA; Morrison AC; Ware L; Klick M; Thomas S; Marks MA
    J Patient Rep Outcomes; 2023 Aug; 7(1):84. PubMed ID: 37610665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing asthma symptoms in children: qualitative research supporting the development of the Pediatric Asthma Diary-Child (PAD-C) and Pediatric Asthma Diary-Observer (PAD-O).
    Bradley H; Trennery C; Jones AM; Lydon A; White F; Williams-Hall R; Arbuckle R; Tomaszewski E; Shih VH; Haughney J; Eisen A; Winders T; Coons SJ; Eremenco S;
    J Patient Rep Outcomes; 2023 Oct; 7(1):104. PubMed ID: 37863864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study.
    Baumann U; Sturm E; Lacaille F; Gonzalès E; Arnell H; Fischler B; Jørgensen MH; Thompson RJ; Mattsson JP; Ekelund M; Lindström E; Gillberg PG; Torfgård K; Soni PN
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101751. PubMed ID: 34182185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial.
    Thompson RJ; Arnell H; Artan R; Baumann U; Calvo PL; Czubkowski P; Dalgic B; D'Antiga L; Durmaz Ö; Fischler B; Gonzalès E; Grammatikopoulos T; Gupte G; Hardikar W; Houwen RHJ; Kamath BM; Karpen SJ; Kjems L; Lacaille F; Lachaux A; Lainka E; Mack CL; Mattsson JP; McKiernan P; Özen H; Rajwal SR; Roquelaure B; Shagrani M; Shteyer E; Soufi N; Sturm E; Tessier ME; Verkade HJ; Horn P
    Lancet Gastroenterol Hepatol; 2022 Sep; 7(9):830-842. PubMed ID: 35780807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Autotaxin Activity Correlates With Pruritus in Pediatric Cholestatic Disorders.
    Kremer AE; Gonzales E; Schaap FG; Oude Elferink RP; Jacquemin E; Beuers U
    J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):530-5. PubMed ID: 26628447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Content validity of a novel patient-reported and observer-reported outcomes assessment to evaluate ocular symptoms associated with infectious conjunctivitis in both adult and pediatric populations.
    Sarda SP; De La Cruz M; Flood EM; Vanya M; Hwang DG; Ta CN; Narvekar A
    Health Qual Life Outcomes; 2019 Oct; 17(1):163. PubMed ID: 31666074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Novel Patient-Reported Outcome (PRO) and Observer-Reported Outcome (ObsRO) Instruments in Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA): ViSIO-PRO and ViSIO-ObsRO.
    Audo I; Patalano F; Naujoks C; Spera C; Fischer MD; Green J; Kay C; Durham T; Williamson N; Bradley H; Barclay M; Boparai K; Banhazi J
    Ophthalmol Ther; 2023 Aug; 12(4):2069-2085. PubMed ID: 37210697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapy.
    Horodniceanu EG; Bal V; Dhatt H; Carter JA; Huang V; Lasch K
    Health Qual Life Outcomes; 2017 Jun; 15(1):129. PubMed ID: 28645270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a signs and symptoms outcome measure for caregivers of patients with methylmalonic acidemia and propionic acidemia (MMAPAQ).
    Sikirica V; Schwartz EJ; Vockley J; Stagni K; Bellenger MA; Banerjee G; Durgam N; Moshkovich O
    Mol Genet Metab; 2024; 143(1-2):108577. PubMed ID: 39303317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Content validity of a newly developed observer-reported measure for pediatric asthma in children aged 2-5 years.
    Zhang Y; Clegg JL; Keith S; McFadden S; Symonds T; Kumar R; Khan AH; Kamat S; Chao J
    J Patient Rep Outcomes; 2022 May; 6(1):55. PubMed ID: 35633412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases.
    Chen HL; Wu SH; Hsu SH; Liou BY; Chen HL; Chang MH
    J Biomed Sci; 2018 Oct; 25(1):75. PubMed ID: 30367658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between pruritus and sleep in participants with primary biliary cholangitis in the Phase 2b GLIMMER trial.
    von Maltzahn R; Mayo MJ; Smith HT; Thompson A; Das S; de Souza AR; Lisi E; Levy C; McLaughlin MM; Jones D
    J Patient Rep Outcomes; 2024 Jun; 8(1):60. PubMed ID: 38862718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Butorphanol as Treatment for Cholestatic Itch.
    Golpanian RS; Yosipovitch G; Levy C
    Dig Dis Sci; 2021 May; 66(5):1693-1699. PubMed ID: 32556969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of sleep in patients with fibromyalgia: qualitative development of the fibromyalgia sleep diary.
    Kleinman L; Mannix S; Arnold LM; Burbridge C; Howard K; McQuarrie K; Pitman V; Resnick M; Roth T; Symonds T
    Health Qual Life Outcomes; 2014 Jul; 12():111. PubMed ID: 25017455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholestatic Itch: Our Current Understanding of Pathophysiology and Treatments.
    Vander Does A; Levy C; Yosipovitch G
    Am J Clin Dermatol; 2022 Sep; 23(5):647-659. PubMed ID: 35900649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.